PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1385625
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1385625
The global urinary catheters market, which was valued at approximately US$ 2 billion in 2024, is expected to experience substantial growth, reaching a projected valuation of around US$ 3.1 billion by the end of 2031. This growth is driven by various factors, including the increasing prevalence of chronic diseases, particularly among the elderly population, and the implementation of favorable reimbursement policies by governments worldwide.
Chronic diseases and comorbidities, especially prevalent among the aging population, necessitate various degrees of catheterization. According to the International Continence Society (ICS), over 45.2% of individuals aged 20 and above suffer from at least one type of lower urinary tract problem (LUTS). This percentage significantly increases among elderly individuals, with approximately 80.7% of elderly men and 79.3% of elderly women experiencing LUTS, including conditions like nocturia. As the global population continues to age, the demand for urinary catheters is expected to rise.
Governments worldwide are increasingly focused on providing favorable reimbursement policies for caregivers and patients who incur expenses related to urinary catheters and other continence products. These policies enable partial or full reimbursement of costs through public and private insurance programs, making urinary catheters more accessible. For instance, in the United States, the Medicare reimbursement coverage allows for the reimbursement of up to 200 sterile intermittent catheters every month, benefiting low-income families, elderly individuals, disabled individuals, and pregnant women.
Despite the promising growth prospects, the urinary catheters market faces challenges, primarily related to urinary tract infections (UTIs) associated with catheter use. According to the Centers for Disease Control and Prevention (CDC), 15% to 25% of hospitalized patients require urinary catheters, with 75% of hospital-acquired UTIs linked to catheter use.
Additionally, the availability and accessibility of disposable incontinence products, such as adult diapers and absorbent pants, pose a potential constraint on the market's growth. Government policies in countries like the United Kingdom, the United States, and Australia offer reimbursement programs for these disposable products, which may divert market demand.
United States: The United States accounted for approximately 36.0% of the global market share in 2022, driven by a growing patient pool, government reimbursement policies, and initiatives to reduce catheter-associated urinary tract infections (CAUTI).
United Kingdom: With a 10.6% market share in 2022, the United Kingdom benefits from increased awareness of catheterization and a relatively high prevalence of urological disorders, including bladder cancer and prostate cancer.
China: China, holding a 6.1% market share in 2022, is poised for expansion due to its aging population with lower urinary tract symptoms (LUTS) and government initiatives aimed at enhancing the quality of care during urinary catheterization.